Atlas Trials

Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss

Clinical trial NCT04370093 · COMPLETED

Trial details

NCT number
NCT04370093
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Nephrolithiasis, Uric Acid
Start date
2019-10-17
Primary completion
2025-05-28
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.